Microbiological monitoring as a component of efficient prevention and treatment of purulent-septic infections in an orthopedics and traumatology department
DOI:
https://doi.org/10.14739/2310-1210.2021.3.229667Keywords:
bacterial multiple drug resistance, purulent-septic infections, antibacterial therapy, biological monitoringAbstract
Efficient monitoring of circulating purulent-septic infectious agents in a clinical setting and a study on antibiotic susceptibility of isolated strains of microorganisms allows identifying changes in the pathogen structure and trends in antibiotic resistance development, which helps to determine the tactics of antibacterial therapy and elaborate appropriate measures.
The aim of the study. Retrospective analysis of the results of microbiological monitoring of purulent-septic infectious (PSI) agents in the Orthopedics and Traumatology Department (OTD) of the Zaporizhzhia Central Ambulance and Emergency Care Hospital over the period 2017–2020 to determine the main antibacterial drugs for empirical therapy.
Materials and methods. We analyzed the bacteriological test results of 664 clinical material samples obtained from OTD patients using bacteriological examination statistical reporting and analytical data of the WHONET 5.6 software.
Results. The main PSI pathogens in the OTD were from the ESKAPE group: E. coli, S. aureus, K. pneumoniae, A. baumannii, E. faecalis, P. aeruginosa and S. epidermidis, P. mirabilis, C. amycolatum. Isolates of E. faecalis were sensitive to vancomycin, linezolid, S. aureus – to linezolid, tigecycline, netilmicin, A. baumannii – to tigecycline. All P. aeruginosa strains were resistant to ticarcillin/clavulanate, cefepime, chloramphenicol, imipenem, meropenem, aztreonam, ciprofloxacin. E. coli and K. pneumoniae were resistant to ampicillin, ticarcillin/clavulanate, aztreonam, ceftriaxone, cefepime. The number of isolates sensitive to piperacillin/tazobactam, carbapenems, levofloxacin, gentamicin, amikacin, chloramphenicol ranged from 37 % to 65 %.
Conclusions. E. coli, S. aureus, K. pneumoniae, A. baumannii, E. faecalis, P. aeruginosa, S. epidermidis, P. mirabilis, C. amycolatum play an important role in the structure of PSI pathogens in the Orthopedics and Traumatology Department of Zaporizhzhia Central Ambulance and Emergency Care Hospital. The antibiotics of choice as the antibacterial empirical therapy for enterococcal infections are vancomycin, linezolid, for staphylococcal infections – vancomycin, linezolid, tigecycline, netilmicin. PSI pathogens continually evolve developing antibiotic resistance, and it is of particular importance to monitor antibiotic susceptibility of microorganisms within the OTD.
References
Shanmuga Vadivoo, N., & Usha, B. (2018). ESKAPE pathogens: Trends in antibiotic resistance pattern. MedPulse International Journal of Microbiology, 7(3), 26-32. https://doi.org/10.26611/1008732
World Health Organization. (2017, February 27). WHO publishes list of bacteria for which new antibiotics are urgently needed. https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed
Terekhova, R. P., Mitish, V. A., Paskhalova, Yu. S., Skladan, G. E., Prudnikova, S. A., & Blatun, L. A. (2016). Vozbuditeli osteomielita dlinnykh kostei i ikh rezistentnost' [Osteomyelitis agents of the long bones and their resistance]. Rany i ranevye infektsii. Zhurnal imeni prof. B. M. Kostyuchenka, 3(2), 24-30. https://doi.org/10.17650/2408-9613-2016-3-2-24-30 [in Russian].
Semak, M. V. (2014). Problemy lecheniya khronicheskogo posleoperatsionnogo osteomielita konechnostei v usloviyakh gnoinosepticheskogo otdeleniya mnogoprofil'nogo statsionara i puti ikh resheniya. (Avtoref. dis. … kand. med. nauk). [Problems of treatment of chronic postoperative osteomyelitis of the extremities in the conditions of purulent septic department of a multidisciplinary hospital and ways to solve them]. (Extended abstract of candidate’s thesis). Sankt-Petersburg. http://medical-diss.com/docreader/585763/a#?page=1 [in Russian].
Bozhkova, S. A., Kasimova, A. R., Tikhilov, R. M., Polyakova, E. M., Rukina, A. N., Shabanova, V. V., & Liventsov, V. N. (2018). Neblagopriyatnye tendentsii v etiologii ortopedicheskoi infektsii: rezul'taty 6-letnego monitoringa struktury i rezistentnosti vedushchikh vozbuditelei [Adverse Trends in the Etiology of Orthopedic Infection: Results of 6-Year Monitoring of the Structure and Resistance of Leading Pathogens]. Travmatologiya i ortopediya Rossii, 24(4), 20-31. https://doi.org/10.21823/2311-2905-2018-24-4-20-31 [in Russian].
Sllamniku, S., Raka, L., Haxhija, E. Q., & Murtezani, A. (2017). Subacute Acetabular Osteomyelitis Caused by Proteus Mirabilis. A Case Study. Ortopedia Traumatologia Rehabilitacja, 19(3), 297-300. https://doi.org/10.5604/15093492.1241409
Thorpe, M. A., & Buckwalter, J. A. (1983). Hematogenous Proteus Mirabilis Osteomyelitis. Orthopedics, 6(7), 865-867. https://doi.org/10.3928/0147-7447-19830701-09
Nuraliyev, N. A., & Suvonov, K. Z. (2015). Fenomen bakterial'noi translokatsii - mikrobiologicheskie aspekty [Microbiological Aspects of Bacterial Translocation Phenomenon: Review]. Visnyk problem biolohii i medytsyny, 1(2), 41-46. [in Russian].
Kalt, F., Schulthess, B., Sidler, F., Herren, S., Fucentese, S. F., Zingg, P. O., Berli, M., Zinkernagel, A. S., Zbinden, R., & Achermann, Y. (2018). Corynebacterium Species Rarely Cause Orthopedic Infections. Journal of Clinical Microbiology, 56(12), Article e01200-18. https://doi.org/10.1128/JCM.01200-18
Bayram, S., Bilgili, F., Anarat, F. B., & Saka, E. (2019). Subacute Osteomyelitis of the Fibula due to Corynebacterium striatum in an Immunocompetent Child. A Case Report. JBJS Case Connector, 9(2), Article e0220. https://doi.org/10.2106/JBJS.CC.18.00220
Sengupta, M., Naina, P., Balaji, V., & Anandan, S. (2015). Corynebacterium amycolatum: An Unexpected Pathogen in the Ear. Journal of Clinical and Diagnostic Research, 9(12), DD01-DD3. https://doi.org/10.7860/JCDR/2015/15134.7002
Liubimova, A. V., Shalyapina, N. A., Kolodzhieva, V. V., Riachovskich, S. A., Dmitrieva, O. V., Brodina, T. V., & Shishmakov, A. A. (2016). Epidemiologiya vankomitsin-rezistentnykh enterokokkov v otdeleniyakh razlichnogo profilya [Epidemiology of Vancomycin-Resistant Enterococci in Various Medical Wards]. Epidemiologiya i Vaktsinoprofilaktika, 15(4), 48-52. https://doi.org/10.31631/2073-3046-2016-15-4-48-52 [in Russian].
Winkler, T., Trampuz, A., Renz, N., Perka, C., & Bozhkova, S. A. (2016). Klassifikatsiya i algoritm diagnostiki i lecheniya periproteznoi infektsii tazobedrennogo sustava [Сlassification and algorithm for diagnosis and treatment of hip periprosthetic infection]. Travmatologiya i ortopediya Rossii, (1), 33-45. https://doi.org/10.21823/2311-2905-2016-0-1-33-45 [in Russian].
Shekarabi, M., Hajikhani, B., Chirani, A. S., Fazeli, M., & Goudarzi, M. (2017). Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: A three year study in Tehran, Iran. PLOS ONE, 12(8), Article e0183607. https://doi.org/10.1371/journal.pone.0183607
Salmanov, A. G. (2017). Antibiotikorezistentnost' nozokomial'nykh shtammov Acinetobacter spp. v khirurgicheskikh statsionarakh Ukrainy: rezul'taty mnogotsentrovogo issledovaniya (2009 - 2015 gg.) [Antimicrobial resistance of nosocomial strains of Аcinetobacter spp. in surgical departments in Ukraine: results of prospective multicenter study (2009 - 2015)]. International journal of antiibiotics and probiotics, (1), 70-82. https://doi.org/10.31405/ijap.1-1.17.05 [in Russian].
Salmanov, A. G., Verner, O. M., & Slepova, L. F. (2018). Epidemiolohiia ta antymikrobna rezystentnist Acinetobacter [Epidemiology and antimicrobial resistance of Acinetobacter]. International Journal of Antibiotics and Probiotics, 4-5(4), 46-59. https://doi.org/10.31405/ijap.4-5.18.05 [in Ukrainian].
Salmanov, A. G., & Verner, O. M. (2017). Antybiotykorezystentnist nozokomialnykh shtamiv Rseudomonas aeruginosa v khirurhichnykh statsionarakh Ukrainy: rezultaty bahatotsentrovoho doslidzhennia (2011 - 2015 rr.) [Antibiotic resistance nosocomial strains of Pseudomonas aeruginosa in Ukrainian surgical department: results of prospective multicenter study (2011 - 2015)]. International Journal of Antibiotics and Probiotics, (1), 49-63. https://doi.org/10.31405/ijap.1-1.17.03 [in Ukrainian].
Potochilova, V., Rudneva, K., Pokas, O., & Vishnyakova, G. (2020). Chutlyvist do antybakterialnykh preparativ ta fenotypove vyznachennia faktoriv rezystentnosti u mikroorhanizmiv rodyny Enterobacteriaceae - zbudnykiv ranovykh infektsii [Sensitivity to antibacterial drugs and phenotypic determination of resistance factors in microorganisms of the Enterobacteriaceae family - pathogens of wound infections]. Visnyk problem biolohii i medytsyny, (3), 208-213. https://doi.org/10.29254/2077-4214-2020-3-157-208-213 [in Ukrainian].
Maxson, B., Serrano-Riera, R., Bender, M., & Sagi, C. (2015). Vancomycin and Cefepime Antibiotic Prophylaxis for Open Fractures Reduces the Infection Rates in Grade III Open Fractures Compared to Cefazolin and Gentamicin, Avoids Potential Nephrotoxicity, and Does Not Result in Antibiotic Resistance with MRSA. Orthopaedic Trauma Association Infection & General Interest II: Orthopaedic Trauma Association’s 31st Annual Meeting (p. 296). Rosemont. https://ota.org/education/meetings-and-courses/abstracts/vancomycin-and-cefepime-antibiotic-prophylaxis-open
Hrytsai, M. P., Kolov, H. B., & Tsokalo, V. M. (2016). Infektsiini uskladnennia pislia nakistkovoho ta vnutrishnokistkovoho osteosyntezu [Infectious complications after external fixation and internal fixation]. Zdorovia Ukrainy, (3. Khirurhiia. Ortopediia. Travmatolohiia), 36-38. https://health-ua.com/wp-content/uploads/2016/11/Book_hirurg3-optimiz.pdf [in Ukrainian].
Polishchuk, N. M., Kyryk, D. L., Yurchuk, I. Ye., Filippova, O. M., Lishchenko, T. M., & Yehorovа, S. V. (2020). Biolohichni vlastyvosti osnovnykh zbudnykiv hniino-zapalnykh zakhvoriuvan u khirurhichnykh khvorykh Zaporizkoi likarni shvydkoi dopomohy [Biological properties of the major causes factors of purulently inflammatory diseases of surgical patients in Zaporizhzhia Clinical Hospital of Emergency and Critical Care Medicine]. Current issues in pharmacy and medicine: science and practice, 13(2), 271-277. https://doi.org/10.14739/2409-2932.2020.2.207203 [in Ukrainian].
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
